BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37923774)

  • 1. Quantification of rare somatic single nucleotide variants by droplet digital PCR using SuperSelective primers.
    Pablo-Fontecha V; Hernández-Illán E; Reparaz A; Asensio E; Morata J; Tonda R; Lahoz S; Parra C; Lozano JJ; García-Heredia A; Martínez-Roca A; Beltran S; Balaguer F; Jover R; Castells A; Trullàs R; Podlesniy P; Camps J
    Sci Rep; 2023 Nov; 13(1):18997. PubMed ID: 37923774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of low-level parental somatic mosaicism for clinically relevant SNVs and indels identified in a large exome sequencing dataset.
    Domogala DD; Gambin T; Zemet R; Wu CW; Schulze KV; Yang Y; Wilson TA; Machol I; Liu P; Stankiewicz P
    Hum Genomics; 2021 Dec; 15(1):72. PubMed ID: 34930489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inconsistency and features of single nucleotide variants detected in whole exome sequencing versus transcriptome sequencing: A case study in lung cancer.
    O'Brien TD; Jia P; Xia J; Saxena U; Jin H; Vuong H; Kim P; Wang Q; Aryee MJ; Mino-Kenudson M; Engelman JA; Le LP; Iafrate AJ; Heist RS; Pao W; Zhao Z
    Methods; 2015 Jul; 83():118-27. PubMed ID: 25913717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the Accuracy of Single-Nucleotide Variant Diagnosis Using On-Off Discriminating Primers.
    Shin J; Jung C
    Biosensors (Basel); 2023 Mar; 13(3):. PubMed ID: 36979592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
    Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of single nucleotide variants using position-specific error estimation in deep sequencing data.
    Kleftogiannis D; Punta M; Jayaram A; Sandhu S; Wong SQ; Gasi Tandefelt D; Conteduca V; Wetterskog D; Attard G; Lise S
    BMC Med Genomics; 2019 Aug; 12(1):115. PubMed ID: 31375105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple method to estimate the in-house limit of detection for genetic mutations with low allele frequencies in whole-exome sequencing analysis by next-generation sequencing.
    Miura T; Yasuda S; Sato Y
    BMC Genom Data; 2021 Feb; 22(1):8. PubMed ID: 33602132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized Mutation Detection in Circulating Tumor DNA for Monitoring Colorectal Tumor Burden Using a Cancer-Associated Gene Sequencing Panel.
    Sato KA; Hachiya T; Iwaya T; Kume K; Matsuo T; Kawasaki K; Abiko Y; Akasaka R; Matsumoto T; Otsuka K; Nishizuka SS
    PLoS One; 2016; 11(1):e0146275. PubMed ID: 26727500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and Quantification of Mosaic Genomic DNA Variation in Primary Somatic Tissues Using ddPCR: Analysis of Mosaic Transposable-Element Insertions, Copy-Number Variants, and Single-Nucleotide Variants.
    Zhou B; Haney MS; Zhu X; Pattni R; Abyzov A; Urban AE
    Methods Mol Biol; 2018; 1768():173-190. PubMed ID: 29717444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study.
    Haider Z; Wästerlid T; Spångberg LD; Rabbani L; Jylhä C; Thorvaldsdottir B; Skaftason A; Awier HN; Krstic A; Gellerbring A; Lyander A; Hägglund M; Jeggari A; Rassidakis G; Sonnevi K; Sander B; Rosenquist R; Tham E; Smedby KE
    Front Oncol; 2023; 13():1176698. PubMed ID: 37333831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germ-line and somatic EPHA2 coding variants in lens aging and cataract.
    Bennett TM; M'Hamdi O; Hejtmancik JF; Shiels A
    PLoS One; 2017; 12(12):e0189881. PubMed ID: 29267365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted RNA sequencing for upfront analysis of actionable driver alterations in non-small cell lung cancer.
    Claerhout S; Lehnert S; Vander Borght S; Spans L; Dooms C; Wauters E; Vansteenkiste J; Weynand B; Deraedt K; Bourgain C; Vanden Bempt I
    Lung Cancer; 2022 Apr; 166():242-249. PubMed ID: 35378489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Droplet digital polymerase chain reaction assay and peptide nucleic acid-locked nucleic acid clamp method for RHOA mutation detection in angioimmunoblastic T-cell lymphoma.
    Tanzima Nuhat S; Sakata-Yanagimoto M; Komori D; Hattori K; Suehara Y; Fukumoto K; Fujisawa M; Kusakabe M; Matsue K; Wakamatsu H; Shimadzu M; Chiba S
    Cancer Sci; 2018 May; 109(5):1682-1689. PubMed ID: 29493850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-level parental somatic mosaic SNVs in exomes from a large cohort of trios with diverse suspected Mendelian conditions.
    Gambin T; Liu Q; Karolak JA; Grochowski CM; Xie NG; Wu LR; Yan YH; Cao Y; Coban Akdemir ZH; Wilson TA; Jhangiani SN; Chen E; Eng CM; Muzny D; Posey JE; Yang Y; Zhang DY; Shaw C; Liu P; Lupski JR; Stankiewicz P
    Genet Med; 2020 Nov; 22(11):1768-1776. PubMed ID: 32655138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-generation sequencing with comprehensive bioinformatics analysis facilitates somatic mosaic APC gene mutation detection in patients with familial adenomatous polyposis.
    Kim B; Won D; Jang M; Kim H; Choi JR; Kim TI; Lee ST
    BMC Med Genomics; 2019 Jul; 12(1):103. PubMed ID: 31269945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced approach for comprehensive mtDNA genome testing in mitochondrial disease.
    Wang J; Balciuniene J; Diaz-Miranda MA; McCormick EM; Aref-Eshghi E; Muir AM; Cao K; Troiani J; Moseley A; Fan Z; Zolkipli-Cunningham Z; Goldstein A; Ganetzky RD; Muraresku CC; Peterson JT; Spinner NB; Wallace DC; Dulik MC; Falk MJ
    Mol Genet Metab; 2022 Jan; 135(1):93-101. PubMed ID: 34969639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing.
    Holm M; Andersson E; Osterlund E; Ovissi A; Soveri LM; Anttonen AK; Kytölä S; Aittomäki K; Osterlund P; Ristimäki A
    PLoS One; 2020; 15(11):e0239819. PubMed ID: 33237900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-exome sequencing identified mutational profiles of high-grade colon adenomas.
    Lee SH; Jung SH; Kim TM; Rhee JK; Park HC; Kim MS; Kim SS; An CH; Lee SH; Chung YJ
    Oncotarget; 2017 Jan; 8(4):6579-6588. PubMed ID: 28179590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Aberrant Alteration of Genome in Colorectal Cancer by Exome Sequencing.
    Liang Y; Jiang L; Zhong X; Hochwald SN; Wang Y; Huang L; Nie Q; Huang H; Xu JF
    Am J Med Sci; 2019 Nov; 358(5):340-349. PubMed ID: 31445671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
    LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
    PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.